Please login to the form below

Not currently logged in
Email:
Password:

InnoPharma appoints Deborah DuFresne as VP

Will head strategic portfolio selection and management

Deborah DuFresne has joined InnoPharma as VP, strategic portfolio selection and management.

She joins the US-based company from Impax Laboratories where she was senior director, project management, product identification and development.

DuFresne has also held senior roles at Fera Pharmaceuticals, Sandoz and Apotex.

"Deborah's broad generic and specialty pharmaceutical experience and extensive product knowledge will be vital to InnoPharma as we seek to enhanc our portfolio in a strategic manner,” said InnoPharma's president and CEO Dr Navneet Puri.

“We look forward to working with Deborah as we continue to build our business and execute on our goals."

13th August 2013

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...